Redox-Based Targeting of Signaling Pathways as a Therapeutic Approach

A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".

Deadline for manuscript submissions: 30 September 2026 | Viewed by 1911

Special Issue Editors


E-Mail Website
Guest Editor
College of Medicine, Chonnam National University, Gwangju, Republic of Korea
Interests: reactive sulfur species

E-Mail Website
Guest Editor Assistant
Departmet of Biochemistry, Department of Biomedical Sciences, Chonnam National University Medical School, Gwangju, Republic of Korea
Interests: cancer biology; neurodegenerative diseases; neurophysiology

Special Issue Information

Dear Colleagues,

The field of redox regulation has been developing considerably, with research increasingly highlighting its critical role in human health and disease. It is well established that physiological processes are tightly governed by cellular signaling pathways, which control cell metabolism, survival, and growth. Although numerous studies have demonstrated that redox regulation influences signaling pathways, research on the substances specifically targeting redox signaling as a therapeutic approach remains limited.

Emerging evidence suggests that the dysregulation of cellular signaling significantly contributes to ageing and pathological processes in various conditions, including cancer, neurological disorders, cardiovascular diseases, metabolic malfunctions, ischemia–reperfusion injury, and even senescence. Thus, therapeutic strategies based on modulating such signaling pathways provide promising interventions. Several natural compounds or small molecules have been identified as potential activators or inhibitors of signaling pathways and are currently under investigation in preclinical and clinical settings. Notably, some cellular signaling regulators are considered redox-sensitive molecules, including kinases (e.g., AMPK, MAPKs), phosphatases (e.g., PTPs), or transcription factors (e.g., Nrf2, NF-κB). In contrast with nonspecific ROS-scavenging therapy, the selective modulation of these redox-sensitive proteins or enzymes may offer a more precise and effective approach.

In this Special Issue, we focus on advances in the redox-based modality of treatment that target associated cellular signaling pathways.

Prof. Dr. Seung-rock Lee
Guest Editor

Dr. Dhiraj Kumar Sah
Guest Editor Assistant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cellular signaling
  • redox-based
  • therapeutic intervention
  • human disease
  • longevity

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

15 pages, 3595 KB  
Communication
Biosacetalin (1,1-Diethoxyethane) Prolongs Survival and Alleviates Cachexia in the NSG Mice Bearing Neuroblastoma SH-SY5Y Cells
by Dhiraj Kumar Sah, Thang Nguyen Huu, Jin Myung Choi, Vu Hoang Trinh, Hyun Joong Yoon and Seung-Rock Lee
Antioxidants 2026, 15(4), 521; https://doi.org/10.3390/antiox15040521 - 21 Apr 2026
Viewed by 533
Abstract
Neuroblastoma remains a formidable pediatric malignancy characterized by profound metabolic plasticity and limited therapeutic responsiveness in high-risk disease. Emerging evidence positions the interplay between Reactive Oxygen Species (ROS) and the metabolic sentinel AMP-activated protein kinase (AMPK) as a critical regulator of tumor metabolic [...] Read more.
Neuroblastoma remains a formidable pediatric malignancy characterized by profound metabolic plasticity and limited therapeutic responsiveness in high-risk disease. Emerging evidence positions the interplay between Reactive Oxygen Species (ROS) and the metabolic sentinel AMP-activated protein kinase (AMPK) as a critical regulator of tumor metabolic stress and apoptotic susceptibility, with additional implications in the systemic pathology of Cancer Cachexia. Building on our previous work demonstrating that 1,1-Diethoxyethane (1,1-DEE; Biosacetalin), a volatile aroma compound inhibits mitochondrial complex I, induces ROS production, and activates AMPK-PGC1α-mediated mitochondrial biogenesis accompanying enhancement of aerobic respiration, leading to anti-Warburg effect. We identify 1,1-DEE as a previously unrecognized metabolic modulator with potent antitumor activity. 1,1-DEE triggers ROS-induced AMPK activation, leading to apoptotic elimination of neuroblastoma cells (SH-SY5Y), robust suppression of tumor growth, and significant prolongation of survival (median survival 77 days) in tumor-bearing NSG mice. Strikingly, 1,1-DEE simultaneously alleviates cancer-associated cachexia by preserving body weight. Mechanistically, our findings reveal a ROS–AMPK–centered signaling axis through which 1,1-DEE integrates tumor-selective cytotoxicity with systemic metabolic protection, highlighting a unified therapeutic strategy for targeting both tumor progression and cachexia in neuroblastoma. Full article
(This article belongs to the Special Issue Redox-Based Targeting of Signaling Pathways as a Therapeutic Approach)
Show Figures

Figure 1

Review

Jump to: Research

17 pages, 610 KB  
Review
Redox-Guided Epigenetic Signaling in Cancer: miRNA–DNMT Feedback Loops as Epigenetic Memory Modulates
by Moon Nyeo Park
Antioxidants 2026, 15(3), 295; https://doi.org/10.3390/antiox15030295 - 27 Feb 2026
Cited by 2 | Viewed by 933
Abstract
Epigenetic dysregulation is a central driver of cancer progression, therapeutic resistance, and phenotypic plasticity. Among epigenetic mechanisms, microRNAs (miRNAs) and DNA methyltransferases (DNMTs) engage in reciprocal regulatory interactions that extend beyond transient gene control. Emerging evidence indicates that DNMT–miRNA feedback loops function as [...] Read more.
Epigenetic dysregulation is a central driver of cancer progression, therapeutic resistance, and phenotypic plasticity. Among epigenetic mechanisms, microRNAs (miRNAs) and DNA methyltransferases (DNMTs) engage in reciprocal regulatory interactions that extend beyond transient gene control. Emerging evidence indicates that DNMT–miRNA feedback loops function as epigenetic memory units, stabilizing malignant cell states and enabling durable phenotypic inheritance even after removal of initiating stimuli under conditions shaped by persistent redox and stress signaling cues. In this review, we synthesize mechanistic, computational, and translational studies demonstrating how double-negative DNMT–miRNA feedback architectures generate bistable regulatory circuits that lock cancer cells into epithelial–mesenchymal transition, stem-like, and therapy-resistant states through redox-sensitive regulatory thresholds rather than static epigenetic alterations. This framework provides a unifying explanation for why transient environmental or therapeutic cues can induce long-lasting epigenetic reprogramming and why conventional single-target epigenetic inhibitors often fail to achieve durable clinical responses. Building on this concept, we propose that herbal medicines and plant-derived phytochemicals act as epigenetic reset signals capable of destabilizing pathological epigenetic attractor states encoded by DNMT–miRNA memory circuits by modulating intracellular redox balance and redox-responsive signaling pathways. Owing to their multi-component and systems-level regulatory properties, herbal interventions modulate miRNA expression, DNMT activity, and upstream stress-responsive pathways in a coordinated manner, facilitating transitions from memory-dominated states toward renewed epigenetic plasticity. We further discuss the translational implications of combining miRNA-based therapies with herbal medicine as a strategy for epigenetic reprogramming rather than transient suppression within a redox-guided therapeutic framework. Finally, we address key challenges and clinical feasibility considerations, including delivery, heterogeneity, and safety, and outline future directions for biomarker-guided and systems-informed epigenetic therapies that incorporate redox state as a functional determinant of epigenetic responsiveness. By reframing DNMT–miRNA interactions through the lens of epigenetic memory, this review highlights miRNA–herbal combination strategies as a forward-looking approach for overcoming therapeutic resistance and achieving durable reprogramming in cancer through selective manipulation of redox-sensitive epigenetic signaling circuits. Full article
(This article belongs to the Special Issue Redox-Based Targeting of Signaling Pathways as a Therapeutic Approach)
Show Figures

Figure 1

Back to TopTop